GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neural Therapeutics Inc (FRA:M6B) » Definitions » Notes Receivable

Neural Therapeutics (FRA:M6B) Notes Receivable : €0.00 Mil (As of Jan. 2025)


View and export this data going back to 2025. Start your Free Trial

What is Neural Therapeutics Notes Receivable?

Neural Therapeutics's Notes Receivable for the quarter that ended in Jan. 2025 was €0.00 Mil.


Neural Therapeutics Notes Receivable Historical Data

The historical data trend for Neural Therapeutics's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neural Therapeutics Notes Receivable Chart

Neural Therapeutics Annual Data
Trend Jul20 Jul21 Jul22 Jul23 Jul24
Notes Receivable
0.13 - - - -

Neural Therapeutics Quarterly Data
Jul20 Jul21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Neural Therapeutics Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Neural Therapeutics Notes Receivable Related Terms

Thank you for viewing the detailed overview of Neural Therapeutics's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Neural Therapeutics Business Description

Traded in Other Exchanges
Address
130 Adelaide Street, Suite 3002, Toronto, ON, CAN, M5H 3P5
Neural Therapeutics Inc is a wholly-owned subsidiary of High Fusion focused on ethnobotanical drug discovery and development company. Neural Therapeutics is focused on developing products and conducting research on the psychoactive cacti plants with the primary objective to find where the historical use in traditional medicine proves to be effective and capitalizing on the opportunities that can be applied in modern medical and natural health products markets.

Neural Therapeutics Headlines

No Headlines